BlackRock’s PLx Pharma Inc. Common Stock PLXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-415,017
| Closed | -$54K | – | 5708 |
|
|
2023
Q1 | $54K | Buy |
415,017
+1,497
| +0.4% | +$304 | ﹤0.01% | 5100 |
|
|
2022
Q4 | $67.9K | Buy |
413,520
+733
| +0.2% | +$307 | ﹤0.01% | 5151 |
|
|
2022
Q3 | $268K | Sell |
412,787
-2,471
| -0.6% | -$3.64K | ﹤0.01% | 4898 |
|
|
2022
Q2 | $1.01M | Buy |
415,258
+8,278
| +2% | +$23K | ﹤0.01% | 4529 |
|
|
2022
Q1 | $1.64M | Sell |
406,980
-1,594
| -0.4% | -$8.74K | ﹤0.01% | 4465 |
|
|
2021
Q4 | $3.27M | Buy |
408,574
+122,296
| +43% | +$1.43M | ﹤0.01% | 4190 |
|
|
2021
Q3 | $5.53M | Buy |
286,278
+173,297
| +153% | +$3.03M | ﹤0.01% | 3920 |
|
|
2021
Q2 | $1.56M | Buy |
112,981
+112,633
| +32,366% | +$1.33M | ﹤0.01% | 4375 |
|
|
2021
Q1 | $3K | Sell |
348
-1,637
| -82% | -$12K | ﹤0.01% | 5193 |
|
|
2020
Q4 | $11K | Hold |
1,985
| – | – | ﹤0.01% | 4843 |
|
|
2020
Q3 | $6K | Hold |
1,985
| – | – | ﹤0.01% | 4846 |
|
|
2020
Q2 | $6K | Sell |
1,985
-7,186
| -78% | -$21.7K | ﹤0.01% | 4834 |
|
|
2020
Q1 | $21K | Sell |
9,171
-297
| -3% | -$1.36K | ﹤0.01% | 4619 |
|
|
2019
Q4 | $41K | Sell |
9,468
-66
| -0.7% | -$310 | ﹤0.01% | 4565 |
|
|
2019
Q3 | $48K | Sell |
9,534
-363
| -4% | -$2.11K | ﹤0.01% | 4546 |
|
|
2019
Q2 | $72K | Buy |
9,897
+5,939
| +150% | +$32.2K | ﹤0.01% | 4537 |
|
|
2019
Q1 | $21K | Sell |
3,958
-410
| -9% | -$2K | ﹤0.01% | 4597 |
|
|
2018
Q4 | $7K | Buy |
4,368
+320
| +8% | +$1.14K | ﹤0.01% | 4711 |
|
|
2018
Q3 | $17K | Buy |
4,048
+99
| +3% | +$372 | ﹤0.01% | 4676 |
|
|
2018
Q2 | $15K | Buy |
3,949
+462
| +13% | +$1.89K | ﹤0.01% | 4712 |
|
|
2018
Q1 | $12K | Sell |
3,487
-50
| -1% | -$317 | ﹤0.01% | 4633 |
|
|
2017
Q4 | $25K | Buy |
3,537
+488
| +16% | +$3.38K | ﹤0.01% | 4536 |
|
|
2017
Q3 | $19K | Sell |
3,049
-110
| -3% | -$706 | ﹤0.01% | 4613 |
|
|
2017
Q2 | $19K | Buy |
3,159
+922
| +41% | +$6.75K | ﹤0.01% | 4666 |
|
|
2017
Q1 | $23K | Buy |
+2,237
| New | +$24.3K | ﹤0.01% | 4596 |
|
Other funds holding PLXP
BlackRock's PLXP Position: Q2 2023 in Review
BlackRock sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 415,017 shares — an estimated $54K sold.
BlackRock first reported a position in PLXP in Q1 2017 and held it in 25 quarters. The position peaked at $5.53M in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.
- BlackRock reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- BlackRock sold 415,017 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $54K.
- BlackRock first reported a position in PLx Pharma Inc. Common Stock in Q1 2017 and held it in 25 quarters.
- BlackRock's PLx Pharma Inc. Common Stock position peaked at $5.53M in Q3 2021.
- 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.
Based on BlackRock's 13F filing for Q2 2023, filed 11 Aug 2023.